#7 Newsletter – JP Jenkins
Seventh Edition
This month we announced another new client – Destiny Pharma plc and we also have Sondrel going live this Thursday! We have Bowleven plc and BiVictriX Therapeutics plc going live in September.
We are delighted to announce the following new admissions to JP Jenkins:
Destiny Pharma plc (JPJ:DEST), announced it’s shares have been admitted to trade on JP Jenkins.
Destiny Pharma plc, a clinical stage biotechnology company focused on the development and commercialisation of novel medicines to prevent and cure life-threatening infections. Shareholders wishing to trade these securities can do so through their stockbroker. Trades will be conducted at a level that JP Jenkins is able to match a willing seller and a willing buyer.
To read the full announcement, please use the link below:
Veronika Oswald, Commercial Director of JP Jenkins said: “We would like to welcome another company from the pharmaceutical sector to JP Jenkins. We are delighted to be supporting Destiny Pharma in their transition and growth as a private company.”
BiVictriX Therapeutics plc announced its intention to leave AIM and move to JP Jenkins, for the trading of its Ord shares.
To learn more, see the full RNS below: https://otp.tools.investis.com/clients/uk/bivictrix_therapeutics_ltd/rns/regulatory-story.aspx?cid=2675&newsid=1853190
Bowleven plc announced its intention to leave AIM and move to JP Jenkins, for the trading of its Ord shares.
To learn more, see the full RNS below: https://lnkd.in/e5jABdpQ
Issuer news – Check out the latest updates and news from our clients:
Fulcrum Group – Annual Results
Fulcrum returns to profitability following major strategic turnaround Fulcrum Utility Services Limited “Fulcrum” or the “Group”, the leading multi-utility infrastructure and services provider announces its full year results for the period ending 31 March 2024.The Group is pleased to report growth and a return to profitability as part of its strategic turnaround, which is delivering sustainable, progressive improvements across its operating divisions.
Fulcrum shares are trading on JP Jenkins, to learn more please check out the page here: https://lnkd.in/e2GBCG4tPlease find the full results below: https://lnkd.in/eKFxwjpi
GS Verde Group – Management Buy Out Announcement:
We’re thrilled to announce the successful management buy-out of recruitment agency, NuStaff Recruitment, in a deal advised on by leading dealmakers GS Verde Group, with the support of the Development Bank of Wales!
💼GS Verde Group proudly advised Directors David Matthews and Paul Fletcher on the acquisition, marking a new chapter for the company, first established by the late John Scriven in 1993. Read the full story here: https://lnkd.in/d47qzfZY
Trading – Check out the latest trading results from the past few weeks:
Thrive Renewables PLC:
Monthly Auction (July)
Volume 30,000
Average price £1.925 GBP
Tende Energy:
Date / Quantity / Mid. Price (GBX)
31/07/2024 – 422,707 – 2.00 GBX
31/07/2024 – 500,000 – 2.00 GBX
31/07/2024 – 191158 – 2.00 GBX
31/07/2024 – 41263 – 2.00 GBX
31/07/2024 – 40,500 – 2.00 GBX
08/08/2024 – 14,203,264 – 2.00 GBX
8/08/2024 – 601,454 – 2.00 GBX
8/08/2024 – 1,049,534 – 2.00 GBX
Prax Exploration (DCU):
Date / Quantity / Mid. Price (GBX)
19/08/2024 – 1,745 – 1.6 GBX
30/07/2024 – 20,000 – 1.6 GBX
29/07/2024 – 310,774 – 1.6 GBX
23/07/2024 – 88,000 – 1.6 GBX
23/07/2024 – 9,000 – 1.6 GBX
Scirocco Energy:
Date 09/08/2024
Quantity 55,300
Mid. Price GBX 0.25 GBX
Events – Check out the latest events and webinars:
💰 Money and 👥 People Webinar:
In today’s dynamic business landscape, success hinges on mastering two pivotal elements: 💰 Money and 👥 People. Join us for a collaborative webinar between Horizon37 and JP Jenkins as we delve into actionable insights that bridge these critical domains. The Money – led by Mason Doick, Head Of Corporate at JP Jenkins & The People – led by Katy Tuncer, Founder at Horizon37.
🚀 The Big Two: Money and People
📆 19th September
⏰ 12-1pm
📍 OnlineRegister here: https://buff.ly/45HxQ3e
Charity:
Here at JP Jenkins we continue to support a number of charities, through personal commitments and monetary support. Each year, we continue to support charities like DEBRA UK, Tiny Tickers ‘The Tiny Hearts Charity’, GCHC (Glasgow Children’s Hospital Charity) & London’s Air Ambulance Charity London’s Air Ambulances campaign is required to replace two life‑saving helicopters and keep them flying for years to come 🚁
This is a charity close to our company, as Jonathan Jenkins, the CEO of London Air Ambulance, is the son of our founder John Jenkins – a well regarded city figure and fantastic man.
Learning 101 with JP Jenkins – Check out our latest videos here on:
As always, if you want to learn more about JP Jenkins – please check out the videos below or contact our team on 0207 469 0937 or email info@jpjenkins.com
Want to keep up to date with our companies?
Subscribe to our newsletter and receive latest information on your favourite companies and JP Jenkins news.
